CRISPR-Cas9 Breakthroughs in Genetic Medicine
Recent clinical trials demonstrate unprecedented success in targeting hereditary blood disorders. Researchers at leading institutes report a 94% efficacy rate in modifying pathogenic genes without off-target effects, marking a new era in personalized therapeutics.